Child and Adolescent Psychiatry and Psychotherapy
Medical Director of the Clinic of Child and Adolescent Psychiatry and Psychotherapy and Deputy Director of the Central Institute of Mental Health (CIMH)
Phone: +49 621 1703-4501
Fax: +49 621 1703-4505
Main Medical Building, 3rd Floor, Room 340
Personal consultant / Research Aide Adviser:
Dr. med. Nina Christmann, Phone.: +49 (0)621 1703- 6960, e-mail
Main Medical Building, 3rd Floor, Room 380
The Clinic for Child and Adolescent Psychiatry and Psychotherapy provides state of the art ambulatory and inpatient mental health care for patients from Mannheim and the surrounding communities in the Rhine-Neckar County. To KJP-Health Care
Our research focuses on disorder-specific and transdiagnostic mechanisms of risk, resilience and course of common child psychiatric disorders like ADHD, ASD and associated disorders, on translating findings into innovative prevention and age-adapted, personalized, biomarker-based, staged pharmacological and non-pharmacological treatment programs and guidelines, and on clinical studies to assess the long-term efficacy and safety of pediatric psychopharmacotherapy. A main focus is on longitudinal determinants in epidemiological, clinical, and at-risk cohorts to relate mental, somatic, genetic and environmental determinants using neuropsychology, multimodal imaging, and molecular genetics. The department has strong links with national and international cooperation partners, such as the European Network for Hyperkinetic Disorders (Eunethydis), the Donders Institute, and the IOP. The research activities are organized within five Research Groups.
Cooperative networks and projects
Research is conducted in close intramural cooperation with the CIMH Departments of Neuropsychology, Genetic Epidemiology, Addiction Medicine and the WG ADHD in Adulthood.
The national cooperations with the CAP departments at the Faculty of Medicine of the Universities of Heidelberg and Ulm were established as a Transregional Center of Competence “Child and Adolescent Psychiatry”, following a recommendation of the Medizin-Struktur-Kommission (MSK; federal governmental board for the evaluation of medical faculties) and funded until 2012. Another national network, in which the CIMH CAP department (TB) is critically involved, is the German ADHD-net (www.zentrales-adhs-netz.de) established on behalf of the German Ministry of Health. It aims at supporting a broad health management for patients of all ages suffering from ADHD and promotes national and international interdisciplinary cooperation.
Furthermore, the CIMH CAP department is building up cooperative research networks with various international partners. Members of the the CAP department are part of the European Network for Hyperkinetic Disorders (Eunethydis), respectively the ADHD Guidelines Group of the Eunethydis.
Tthe CIMH CAP department is also involved in the IMAGEN project, a European-Commission funded international multi-site research project which aims to identify biological and environmental factors that might have an influence on risk taking behaviour and mental health in teenagers.
Moreover, the CIMH CAP department is participating as work package leader in various other EU-funded projects (see below, such as the PERS project (studies with risperidone in conduct disorder and psychotic disorders), STOP project (‘medication-related suicidality’ focusing on the effects of selective serotonin re-uptake inhibitors), ADDUCE project (studies on the long-term safety of stimulant medication for the treatment of ADHD), TACTICS project (focusing on addictive and/or compulsive behaviour in children and adolescents: translating pre-clinical results into therapies).
Zentralinstitut für Seelische Gesundheit (ZI) - https://www.zi-mannheim.de